Baseline characteristics of patients with axial spondyloarthritis who completed the study as compared to patients who dropped out.
| Completer (n=19) | Non-Completer (n=57) | p value | |
|---|---|---|---|
| Age, years | 32.5 (7.4) | 32.8 (8.9) | 0.91 |
| Male patients, n (%) | 15 (78.9) | 29 (50.9) | 0.034 |
| Symptomduration, years | 1.1 (1.2) | 1 (1.7) | 0.81 |
| HLA-B27 positivity, n (%) | 18 (94.7) | 44 (77.2) | 0.091 |
| Elevated CRP (CRP>5mg/l), n (%) | 7 (38.9) | 33 (62.3) | 0.088 |
| Fulfilled New York criteria, n (%) | 12 (63.2) | 27 (47.4) | 0.24 |
| Patient global (0-10) | 6.1 (1.9) | 7.2 (1.7) | 0.025 |
| Physician global (0-10) | 5.5 (1.5) | 6.5 (1.2) | 0.007 |
| ASDAS | 3 (0.7) | 3.5 (0.8) | 0.042 |
| BASDAI (0-10) | 5.4 (1.1) | 5.8 (1.3) | 0.27 |
| BASFI (0-10) | 4 (2.1) | 4.4 (2) | 0.41 |
| BASMI (0-10) | 1.2 (1.3) | 2 (1.6) | 0.039 |
| AS-QoL (0-18) | 7.6 (3.9) | 10.1 (3.9) | 0.019 |